234 related articles for article (PubMed ID: 28245287)
1. Study of association and molecular analysis of human papillomavirus in breast cancer of Indian patients: Clinical and prognostic implication.
Islam S; Dasgupta H; Roychowdhury A; Bhattacharya R; Mukherjee N; Roy A; Mandal GK; Alam N; Biswas J; Mandal S; Roychoudhury S; Panda CK
PLoS One; 2017; 12(2):e0172760. PubMed ID: 28245287
[TBL] [Abstract][Full Text] [Related]
2. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
3. Phylogenetic analysis of Human papillomavirus 16 variants isolated from Indian Breast cancer patients showed difference in genetic diversity with that of cervical cancer isolates.
Islam S; Mazumder Indra D; Basu M; Roychowdhury A; Das P; Dasgupta H; Roy A; Alam N; Mondal RK; Roychoudhury S; Panda CK
Virus Res; 2018 Jan; 243():1-9. PubMed ID: 28988982
[TBL] [Abstract][Full Text] [Related]
4. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
6. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
7. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.
Fontecha N; Basaras M; Hernáez S; Andía D; Cisterna R
BMC Cancer; 2016 Nov; 16(1):852. PubMed ID: 27816058
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.
Pande S; Jain N; Prusty BK; Bhambhani S; Gupta S; Sharma R; Batra S; Das BC
J Clin Microbiol; 2008 Mar; 46(3):1060-6. PubMed ID: 18199779
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression.
Mazumder Indra D; Singh RK; Mitra S; Dutta S; Chakraborty C; Basu PS; Mondal RK; Roychoudhury S; Panda CK
Gynecol Oncol; 2011 Dec; 123(3):597-604. PubMed ID: 21911249
[TBL] [Abstract][Full Text] [Related]
10. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
Cheung JL; Cheung TH; Yu MY; Chan PK
Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
[TBL] [Abstract][Full Text] [Related]
11. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18.
Díaz-Tejeda Y; Guido-Jiménez MC; López-Carbajal H; Amador-Molina A; Méndez-Martínez R; Gariglio-Vidal P; Lizano M; García-Carrancá A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452350
[TBL] [Abstract][Full Text] [Related]
12. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer.
Ma C; Zeng C; Jin L; Yang Y; Li P; Chen L; Wang J
Sci Rep; 2015 Nov; 5():16555. PubMed ID: 26560046
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells.
Fan R; Hou WJ; Zhao YJ; Liu SL; Qiu XS; Wang EH; Wu GP
Tumour Biol; 2016 Apr; 37(4):4655-63. PubMed ID: 26508030
[TBL] [Abstract][Full Text] [Related]
14. Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells.
Peña N; Carrillo D; Muñoz JP; Chnaiderman J; Urzúa U; León O; Tornesello ML; Corvalán AH; Soto-Rifo R; Aguayo F
PLoS One; 2015; 10(4):e0123029. PubMed ID: 25830243
[TBL] [Abstract][Full Text] [Related]
15. Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.
Harden ME; Munger K
Virology; 2017 Jul; 507():192-198. PubMed ID: 28448850
[TBL] [Abstract][Full Text] [Related]
16. ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity.
Mikuličić S; Shamun M; Massenberg A; Franke AL; Freitag K; Döring T; Strunk J; Tenzer S; Lang T; Florin L
Front Immunol; 2024; 15():1335302. PubMed ID: 38370412
[TBL] [Abstract][Full Text] [Related]
17. HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.
Gokhale PS; Sonawani A; Idicula-Thomas S; Kerkar S; Tongaonkar H; Mania-Pramanik J
J Med Virol; 2014 Jun; 86(6):968-74. PubMed ID: 24610458
[TBL] [Abstract][Full Text] [Related]
18. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
Ajiro M; Zheng ZM
mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
[TBL] [Abstract][Full Text] [Related]
19. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
20. Virus transcript levels and cell growth rates after naturally occurring HPV16 integration events in basal cervical keratinocytes.
Scarpini CG; Groves IJ; Pett MR; Ward D; Coleman N
J Pathol; 2014 Jul; 233(3):281-93. PubMed ID: 24752734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
